STATEMENTS OF CASH FLOWS (USD $)	3 Months Ended
	Dec. 31, 2014	Dec. 31, 2013
CASH FLOWS FROM OPERATING ACTIVITIES:
Net loss	$ (7,845,318)	$ (4,334,418)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	56,613	56,699
Issuance of common stock and options for services	189,144	137,729
Modification of warrants issued to consultants	0	76,991
Equity based compensation	3,059,791	510,278
Common stock contributed to 401 (k) plan	40,341	37,887
Impairment loss on abandonment of patents	0	240
Loss on retired equipment	313	0
Gain on derivative instruments	(2,162,970)	(1,610,817)
(Increase)/decrease in assets:
Receivables	(74,118)	28,384
Deferred rent	189,277	176,161
Prepaid expenses	133,152	(210,367)
Inventory used for R&D and manufacturing	216,992	(330,629)
Deposits	150,000	(200,000)
Increase/(decrease) in liabilities:
Accounts payable	457,735	(380,943)
Accrued expenses	123,001	232,905
Due to employees	28,389	(105,873)
Deferred rent liability	(1,494)	(749)
Net cash used in operating activities	(5,439,152)	(5,916,522)
CASH FLOWS FROM INVESTING ACTIVITIES:
Purchases of equipment	(17,100)	(8,587)
Net cash used in investing activities	(17,100)	(8,587)
CASH FLOWS FROM FINANCING ACTIVITIES:
Proceeds from issuance of common stock and warrants	6,405,932	19,380,190
Payments on oblgations under capital leases	(2,065)	(2,665)
Net cash provided by financing activities	6,403,867	19,377,525
NET INCREASE IN CASH AND CASH EQUIVALENTS	947,615	13,452,416
CASH AND CASH EQUIVALENTS, BEGINNING OF PERIOD	8,513,620	41,612
CASH AND CASH EQUIVALENTS, END OF PERIOD	9,461,235	13,494,028
ISSUANCE OF WARRANTS:
Increase in derivative liabilities	(460,737)	(7,321,071)
Decrease in additional paid-in capital	460,737	7,321,071
Total	0	0
ISSUANCE OF ADDITIONAL SHARES
Increase in common stock	0	(15,631)
Increase in additional paid-in capital	0	(1,101,786)
Decrease in additional paid-in capital	0	1,117,417
Total	0	0
ISSUANCE OF COMMON STOCK FOR PREPAID SERVICES:
Increase in additional paid-in capital	(6,389)	(55,362)
Increase in prepaid expenses	6,389	55,362
Total	0	0
ACCOUNTS PAYABLE
Increase in research and office equipment	23,715	12,126
Decrease (increase) in capital lease obligation	10	(9,436)
Increase in patent costs	0	9,208
Direct offering costs charged to APIC	0	72,328
Increase in accounts payable	(23,725)	(84,226)
Total	0	0
SUPPLEMENTAL DISCLOSURE OF CASH FLOWS INFORMATION:
Cash expenditures for interest expense	$ 41,670	$ 56,509